ABSTRACT
El manejo del estrabismo restrictivo sigue siendo un problema no resuelto hoy en día.Se presenta un caso de estrabismo restrictivo posquirúrgico severo tras una cirugía de exotropía consecutiva. Describimos a continuación el manejo exitoso mediante una técnica que consiste en envolver el músculo afectado con membrana amniótica o «wrap» en la que añadimos un segundo injerto de membrana amniótica en la reconstrucción de la superficie ocular. (AU)
The management of restrictive strabismus remains an unresolved problem today.A case of severe restrictive strabismus after a consecutive exotropia surgery is presented. We describe the exitosus managment through a technique consist of wrapping with amniotic membrane the affected muscle where we add a second amniotic membraneA graft in the reconstruction of the ocular surface. (AU)
Subject(s)
Humans , Female , Adult , Ophthalmologic Surgical Procedures/methods , Esotropia/surgery , Amnion/transplantation , Treatment Outcome , Visual AcuityABSTRACT
A case of severe restrictive strabismus after a consecutive exotropia surgery is presented. We describe the exitous managment through a technique consist of wrapping with amniotic membrane (AM) the affected muscle where we add a second AM graft in the reconstruction of the ocular Surface.
Subject(s)
Exotropia , Strabismus , Humans , Amnion/transplantation , Strabismus/etiology , Strabismus/surgery , Oculomotor Muscles/surgery , Exotropia/etiology , Exotropia/surgery , Ophthalmologic Surgical Procedures/methodsABSTRACT
Se presenta a una niña de 3 meses de edad con un cuadro febril sin foco y con empeoramiento. La exploración fundoscópica mostró una lesión coroidea en el ojo izquierdo junto con lesiones en otros órganos sugestivas de tuberculosis diseminada. La evolución fue favorable tras tratamiento con cuádruple terapia antibiótica asociada a corticoterapia. La tuberculosis diseminada debe tenerse en cuenta ante un cuadro febril de tórpida evolución. La exploración oftalmológica de estos pacientes es fundamental, ya que, aunque es poco frecuente, los signos característicos de las uveítis posteriores nos orientarán hacia el diagnóstico y tratamiento precoz de esta enfermedad
A three-month old baby girl presented with fever of unknown origin and with signs of worsening of this episode. Funduscopy showed a solitary choroidal lesion in her left eye, as well as extraocular lesions suggesting disseminated tuberculosis. A favourable outcome was achieved after quadruple antibiotic course and cortisone therapy. Disseminated tuberculosis should be considered in cases of fever of unknown origin in children with an unsatisfactory evolution. Ocular examination is mandatory, due to the possible posterior uveitis signs that can help with early diagnosis and treatment of some diseases
Subject(s)
Humans , Female , Infant , Choroid Diseases/diagnosis , Tuberculoma/diagnosis , Tuberculosis, Miliary/diagnosis , Tuberculosis, Ocular/diagnosis , Adrenal Cortex Hormones/therapeutic use , Amikacin/therapeutic use , Antitubercular Agents/therapeutic use , Choroid Diseases/diagnostic imaging , Choroid Diseases/drug therapy , Drug Therapy, Combination , Ethambutol/therapeutic use , Isoniazid/therapeutic use , Ophthalmoscopy , Pyrazinamide/therapeutic use , Rifampin/therapeutic use , Tuberculoma/diagnostic imaging , Tuberculosis, Miliary/drug therapy , Tuberculosis, Ocular/diagnostic imaging , Tuberculosis, Ocular/drug therapy , Uveitis, Posterior/diagnosis , Uveitis, Posterior/drug therapyABSTRACT
A three-month old baby girl presented with fever of unknown origin and with signs of worsening of this episode. Funduscopy showed a solitary choroidal lesion in her left eye, as well as extraocular lesions suggesting disseminated tuberculosis. A favourable outcome was achieved after quadruple antibiotic course and cortisone therapy. Disseminated tuberculosis should be considered in cases of fever of unknown origin in children with an unsatisfactory evolution. Ocular examination is mandatory, due to the possible posterior uveitis signs that can help with early diagnosis and treatment of some diseases.
Subject(s)
Choroid Diseases/diagnosis , Tuberculoma/diagnosis , Tuberculosis, Miliary/diagnosis , Tuberculosis, Ocular/diagnosis , Adrenal Cortex Hormones/therapeutic use , Amikacin/therapeutic use , Antitubercular Agents/therapeutic use , Choroid Diseases/diagnostic imaging , Choroid Diseases/drug therapy , Drug Therapy, Combination , Ethambutol/therapeutic use , Female , Humans , Infant , Isoniazid/therapeutic use , Ophthalmoscopy , Pyrazinamide/therapeutic use , Rifampin/therapeutic use , Tuberculoma/diagnostic imaging , Tuberculosis, Miliary/drug therapy , Tuberculosis, Ocular/diagnostic imaging , Tuberculosis, Ocular/drug therapy , Uveitis, Posterior/diagnosis , Uveitis, Posterior/drug therapyABSTRACT
CASO CLÍNICOS: Presentamos los casos de dos pacientes con carcinoma basocelular periocular palpebral, que recibieron imiquimod tópico al 5%, con buena respuesta. Ambos presentaban un estado funcional que desaconsejaba el tratamiento quirúrgico. CONCLUSIÓN: La crema de imiquimod al 5% ha demostrado ser una alternativa eficaz al tratamiento quirúrgico de tumores basocelulares perioculares, especialmente en aquellos casos en los que la cirugía no es posible
CLINICAL CASE: The cases are presented of two patients with periocular basal cell carcinoma of the eyelid who received topical imiquimod 5%, with a good response. Both had a functional state that contraindicated surgical treatment. CONCLUSION: Imiquimod cream 5% was shown to be an effective alternative to surgical treatment of periocular basal cell carcinoma, especially in those cases where surgery is not possible
Subject(s)
Humans , Male , Female , Middle Aged , Aged, 80 and over , Carcinoma, Basal Cell/pathology , Eyelid Neoplasms/pathology , Immunologic Factors/therapeutic use , Carcinoma, Basal Cell/drug therapy , Eyelid Neoplasms/drug therapy , Administration, Topical , AIDS-Related Opportunistic Infections/diagnosisABSTRACT
CLINICAL CASES: The cases are presented of two patients with periocular basal cell carcinoma of the eyelid who received topical imiquimod 5%, with a good response. Both had a functional state that contraindicated surgical treatment. CONCLUSION: Imiquimod cream 5% was shown to be an effective alternative to surgical treatment of periocular basal cell carcinoma, especially in those cases where surgery is not possible.
Subject(s)
Aminoquinolines/therapeutic use , Antineoplastic Agents/therapeutic use , Carcinoma, Basal Cell/drug therapy , Eyelid Neoplasms/drug therapy , Acquired Immunodeficiency Syndrome/complications , Aminoquinolines/adverse effects , Antineoplastic Agents/adverse effects , Contraindications, Procedure , HIV-Associated Lipodystrophy Syndrome/complications , Humans , Imiquimod , Male , Middle Aged , Plastic Surgery Procedures , Remission Induction , Skin Ulcer/chemically induced , Surgical FlapsABSTRACT
CASO CLÍNICO: Varón de 56 años con el diagnóstico clínico de acromatopsia incompleta. En su estudio genético se encontraron 2 mutaciones en heterocigosis en el gen CNGA3 relacionado con la acromatopsia recesiva. Una de ellas la c.1495C>T, no ha sido previamente informada en otros casos de acromatopsia. DISCUSIÓN: La acromatopsia es una enfermedad retiniana congénita de herencia autosómica recesiva. La tasa de mutaciones en el gen CNGA3, localizado en el cromosoma 2q11, oscila entre el 5 y el 25% de los casos, y en su mayoría son producidas por cambios en la secuencia. Este hallazgo confirma el diagnóstico y nos permite realizar un consejo genético
CASE REPORT: A 56-year old male was diagnosed with incomplete achromatopsia. His molecular genetic analysis showed two heterozygous mutations in the CNGA3 gene associated with autosomal recessive achromatopsia. One of them, c.1495C>T, has not been previously reported in achromatopsia. DISCUSSION: Achromatopsia is a congenital autosomal recessive retinal disorder. Mutations in the CNGA3 gene, located at chromosome positions 2q11, accounts for 5-25% of patients affected with this disorder. The vast majority of mutations are missense. This discovery confirms the clinical diagnosis and it allows us to provide genetic counselling
Subject(s)
Humans , Male , Middle Aged , Color Vision Defects/genetics , Mutation/genetics , Genetic Techniques , HeterozygoteABSTRACT
CASE REPORT: A 56-year old male was diagnosed with incomplete achromatopsia. His molecular genetic analysis showed two heterozygous mutations in the CNGA3 gene associated with autosomal recessive achromatopsia. One of them, c.1495C>T, has not been previously reported in achromatopsia. DISCUSSION: Achromatopsia is a congenital autosomal recessive retinal disorder. Mutations in the CNGA3 gene, located at chromosome positions 2q11, accounts for 5-25% of patients affected with this disorder. The vast majority of mutations are missense. This discovery confirms the clinical diagnosis and it allows us to provide genetic counselling.